| Stage | BJRI | % of rev | MCD | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $389M | 100.00% | $7.1B | 100.00% | MCD ×18.25 |
| Gross profit | $155M | 39.97% | $4.3B | 60.30% | MCD +20.3pp |
| Operating income | $18M | 4.74% | $3.3B | 47.02% | MCD +42.3pp |
| Pre-tax income | $19M | 4.89% | $2.9B | 41.36% | MCD +36.5pp |
| Net income | $19M | 4.83% | $2.4B | 33.27% | MCD +28.4pp |
| Stage | BJRI | MCD | Gap · A − B |
|---|---|---|---|
| Revenue | $389M100.00% | $7.1B100.00% | MCD ×18.25 |
| Gross profit | 39.97%$155M | 60.30%$4.3B | MCD +20.3pp |
| Operating income | 4.74%$18M | 47.02%$3.3B | MCD +42.3pp |
| Pre-tax income | 4.89%$19M | 41.36%$2.9B | MCD +36.5pp |
| Net income |
| 4.83%$19M |
| 33.27%$2.4B |
| MCD +28.4pp |
None
No disclosed counterparties: BJRI.